1996
DOI: 10.1016/s0091-6749(96)80069-8
|View full text |Cite
|
Sign up to set email alerts
|

Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: Different degrees of responsiveness in atopic and nonatopic subjects*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
2
0
2

Year Published

2000
2000
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 38 publications
1
2
0
2
Order By: Relevance
“…This is consistent with the earlier results in CRSwNP and asthma . Atopic patients have been shown to exhibit faster and stronger neutrophil activation in the nasal cavity . Could atopy then be the sole explanation for the elevated nasal MMP and MPO levels detected in the control group; ie, when SPT+ and SPT− subjects were evaluated as one group?…”
Section: Discussionsupporting
confidence: 90%
“…This is consistent with the earlier results in CRSwNP and asthma . Atopic patients have been shown to exhibit faster and stronger neutrophil activation in the nasal cavity . Could atopy then be the sole explanation for the elevated nasal MMP and MPO levels detected in the control group; ie, when SPT+ and SPT− subjects were evaluated as one group?…”
Section: Discussionsupporting
confidence: 90%
“…Today, little is known about the interaction between the microorganisms and the mucous lining of the paranasal sinuses in terms of neutrophilic chemotaxis induction. In healthy people, more neutrophil granulocytes were found in nasal irrigation fluid (35%) than in the tissue itself (26, 33, 34). The continuous influx of neutrophil granulocytes is attributed to the chemotactic effect of IL‐8, which is constitutively synthesized by epithelial cells, glandular cells and leukocytes (31, 35–38).…”
Section: Pathophysiology Of Acute and Chronic Neutrophilic Sinusitismentioning
confidence: 99%
“…Embora esta avaliação não permita localizar o processo inflamatório quando analisado num contexto clínico específico, poderá fornecer informação fidedigna sobre a inflamação do órgão onde ocorreram as manifestações clínicas 20,21 . 36,37,38 .…”
Section: Marcadores Sistémicos De Inflamaçãounclassified